(AGENPARL) – SILVER SPRING mar 25 aprile 2023 FDA approved Qalsody (tofersen) to treat patients with amyotrophic lateral sclerosis (ALS) associated…
Browsing: FDA
(AGENPARL) – WASHINGTON sab 22 aprile 2023 U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra released the…
(AGENPARL) – SILVER SPRING ven 21 aprile 2023 The U.S. Food and Drug Administration is providing an at-a-glance summary of news…
(AGENPARL) – SILVER SPRING ven 21 aprile 2023 FDA and Health Canada will be co-hosting a regional public meeting to provide…
(AGENPARL) – SILVER SPRING gio 20 aprile 2023 FDA and NIH/NCI Center for Cancer Research: Advancing Drug Development in Myelodysplastic Syndromes.…
(AGENPARL) – WASHINGTON gio 20 aprile 2023 Content Files PDFXMLTEXTMetadata download Descriptive Metadata (MODS)Preservation Metadata (PREMIS)All Content and Metadata files,…
(AGENPARL) – SILVER SPRING mar 18 aprile 2023 The U.S. Food and Drug Administration is providing an at-a-glance summary of news…
(AGENPARL) – SILVER SPRING mar 18 aprile 2023 The FDA amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech…
(AGENPARL) – SILVER SPRING lun 17 aprile 2023 FDA approves Omisirge (omidubicel-onlv), a nicotinamide modified allogeneic (donor) cord blood-based cell therapy…
(AGENPARL) – SILVER SPRING lun 17 aprile 2023 The purpose of this public workshop is to discuss topics relevant to the…